AcelRx Pharmaceuticals

AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of therapies for the treatment of pain and other conditions. It offers NanoTab, a tablet for oral transmucosal administration. The company also provides Sufentanil NanoTab PCA system, a sublingual patient-controlled analgesia system with a drug/device combination product candidate for the management of acute post-operative pain in the hospital settings; Sufentanil NanoTab BTP management systems for the treatment option for patients with cancer pain; and Sufentanil/Triazolam NanoTab, which provides analgesia and sedation for minor outpatient procedures. It serves patients, physicians, regulators, and payers. AcelRx Pharmaceuticals, Inc. was founded in 2005 and is based in Redwood City, California.
Type
Public
HQ
Redwood City, US
Employees
36 (est)-28%
AcelRx Pharmaceuticals is headquartered in Redwood City, US

Key People at AcelRx Pharmaceuticals

James Welch

James Welch

CFO
Richard King

Richard King

President and CEO

AcelRx Pharmaceuticals Locations

Redwood City, US

AcelRx Pharmaceuticals Metrics

AcelRx Pharmaceuticals Summary

Market capitalization

$134 M

Closing share price

$2.9
AcelRx Pharmaceuticals's latest market capitalization is $134 M.

AcelRx Pharmaceuticals Market Value History

22% of current employees of AcelRx Pharmaceuticals are female and 78% are male.

AcelRx Pharmaceuticals News

AcelRx Pharmaceuticals Company Life

You may also be interested in